Price
No data yet.
Social Signal Score
Revenue
$0.00Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Garo H. Armen
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 1
- Beta
- 1.07
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- -9.54
Financials
Revenue
$0.00Net Income
$-963.6KEBITDA
$-961.2KFree Cash Flow
$-944.3KEPS (diluted)
$-0.53Shares Outstanding (diluted)
1.81M-56.2%Operating Expenses
$207.9KCash & Debt
$566.0KDividend per Share
$479749712.15Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $-5.16M | $-3.45 |
| 2024 | $0.00 | $-5.53M | $-1.13 |
| 2023 | $0.00 | $-5.00M | $-1.15 |
| 2022 | $0.00 | $-3.56M | $-0.82 |
| 2021 | $0.00 | $-4.52M | $-1.24 |
| 2020 | $0.00 | $-2.55M | $-1.00 |
| 2019 | $0.00 | $-1.75M | $-0.69 |
| 2018 | $0.00 | $-2.56M | $-1.00 |
| 2017 | $0.00 | $-2.26M | $-0.88 |
| 2016 | $0.00 | $-2.28M | $-1.72 |
| 2015 | $0.00 | $-476.0K | $-73.23 |
| 2014 | $0.00 | $-1.08M | $-166.86 |
| 2013 | $85.0K | $-1.03M | $-632.00 |
| 2010 | $40.03M | $-19.73M | $-193401.96 |
Valuation
PTIXhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
70Social Signal Score
Mentions (1)
- Newsaccessnewswire.com·6h ago·Negative
…ical packages; IND submission remains on track for the fourth quarter of 2026 NEW YORK, NY / ACCESS Newswire / August 20, 2026 / Protagenic Therapeutics, Inc. (OTCQB:PTIX), a clinical-stage biopharmaceutical company developing novel peptide-based treatments for stress-related neuropsychiatric disorders, today announced that it has received written responses from the U.S. Food and Drug Administration (FDA) to its Type B pre-Investigational New Drug (pre-IND) meeting request for PT00114, the Compa…
View source ↗
Earnings
Tue, Nov 17(in 3 months)
Consensus estimate $-2.80 per share
Typical surprise +88.8% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 19$-0.53 vs $-4.48beat
- Wed, Aug 19$-0.53 vs $-4.48beat
- Mon, Mar 9$-0.47 vs $-4.48beat
- Wed, Nov 26$-0.47 vs $-4.48beat
Estimates and results for PTIX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by PTIX officers and directors.
- Bought
- $7.0m
- Sold
- —
35 trades
0 trades
- Armen Garo Hbought
- Armen Garo Hbought
- Armen Garo Hbought
- Armen Garo Hbought
- Armen Garo Hbought
- Arrow Alexander K.bought
- Arrow Alexander K.bought
- Arrow Alexander K.bought
63 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.